Skip to content

The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs

A Prospective Randomized Pilot Study on the Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00212459
Enrollment
14
Registered
2005-09-21
Start date
2005-05-31
Completion date
2008-04-30
Last updated
2013-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemophilia A, Hemophilia B

Keywords

Bleeding logs, Factor Infusions

Brief summary

The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logs.

Detailed description

The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logs.To do this subjects will be randomized into a control group and a group who will receive consistent counselling by a pharmacist about their bleeding logs. The aims of the study are: * To provide a new method of bleeding and treatment documentation in the home setting (logs) to adolescent subjects with Hemophilia A or B * To counsel these subjects about adherence to their treatment regimen prescribed by physician and the importance of keeping accurate documentation of each bleeding episode and its treatment. * To improve maintenance of logs, to allow for 1) assessment of bleeding frequency and treatment efficacy and 2) early detection of target joint bleeding and the potential need for prophylactic factor replacement.

Interventions

BEHAVIORALCounseling

Patients are contacted every two weeks after initial counseling to discuss the completion of bleeding records.

BEHAVIORALControl

No more contacts are made with control patients after the initial counseling session.

Sponsors

New York Presbyterian Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
12 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

* Ages 12 through 20 * Severe or moderate Hemophilia A or B * Self-infusing or transitioning to self infusion in the home setting * Already assigned responsibility of monitoring bleeding logs

Exclusion criteria

* Not meeting inclusion criteria

Design outcomes

Primary

MeasureTime frame
Study and control groups will be compared with respect to the % of bleeds reported to the HTC and % of recommended therapy recorded in bleeding logs after a 6 month period6 months

Secondary

MeasureTime frame
Study and control groups will be compared with respect to time between initiation of target joint bleeding and the identification and treatment of such by HTC personnel6 months
Clotting factor consumption and the cost of therapy in each group will be compared6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026